The Latest Breaking News from Vaccine

‘We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission,’ Moderna legal officer says

Pharmaceutical giant Pfizer’s (PFE) omicron-targeted booster doses could soon be authorized this fall. The company has benefited largely from the pandemic and its vaccine rollouts. Now let’s find out if PFE is a Buy now as it prepares to roll out its booster doses….

Across the UK Covid infections have fallen to their lowest level in two months

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

Fainting and fatigue may signal onset of variant, experts say

LOS ANGELES — With monkeypox on the rise, Lady Kay decided to hold off on meeting clients in hotel rooms or private dungeons.

Omicron’s mutations impaired vaccine effectiveness, CDC says

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

Anti-lockdown advocates have been claiming online this week that Victoria's Chief Health Officer Brett Sutton admitted that vaccines never worked. But that's not what he said.